• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证和比较第 7 版和第 8 版 AJCC 分期系统用于非转移性鼻咽癌,以及来自香港、广州和广西的分期系统。

Validation and comparison of the 7th and 8th edition of AJCC staging systems for non-metastatic nasopharyngeal carcinoma, and proposed staging systems from Hong Kong, Guangzhou, and Guangxi.

机构信息

Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.

Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

出版信息

Oral Oncol. 2017 Sep;72:65-72. doi: 10.1016/j.oraloncology.2017.07.011.

DOI:10.1016/j.oraloncology.2017.07.011
PMID:28797463
Abstract

OBJECTIVES

We aimed to validate and compare the 7th and 8th edition of AJCC staging systems for non-metastatic nasopharyngeal carcinoma, and proposed staging systems from Hong Kong, Guangzhou, and Guangxi.

MATERIALS AND METHODS

We retrospectively included 899 patients treated between November 5, 2002 and May 27, 2010. Separation and discrimination of each staging system in overall survival were primarily compared.

RESULTS

Compared with the 7th AJCC, the 8th AJCC and all proposed staging systems well separated across T-classification. T-classification from Guangzhou seemed to perform best in discrimination (C-index 0.6454), followed by the 8th AJCC (0.6451), the 7th AJCC (0.6386), Hong Kong (0.6376) and Guangxi (0.5889). For N-classification, no staging systems improved the weakness of the 7th AJCC in separating N2 and N1, except that suggestion from Guangzhou showed higher potential (P=0.096). Besides, N-classification from Guangzhou had a C-index of 0.6444, larger than that of the 8th AJCC (0.6235), the 7th AJCC (0.6179), Hong Kong (0.6175) and Guangxi (0.6175). Accordingly, stage group of staging system from Guangzhou showed higher discrimination (C-index 0.6839), compared with the 8th AJCC (0.6791), the 7th AJCC (0.6766), Hong Kong (0.6765) and Guangxi (0.6688), despite that stage I and II remained inseparable (P=0.322).

CONCLUSIONS

The 8th AJCC staging system appeared to be better than the 7th AJCC. But the proposed staging system from Guangzhou was more likely to improve the separation and discrimination abilities.

摘要

目的

本研究旨在验证和比较第七版和第八版 AJCC 分期系统在非转移性鼻咽癌中的应用,并提出来自香港、广州和广西的分期系统。

材料和方法

本研究回顾性纳入了 2002 年 11 月 5 日至 2010 年 5 月 27 日期间接受治疗的 899 例患者。首先比较了每个分期系统在总生存中的分离和判别能力。

结果

与第七版 AJCC 相比,第八版 AJCC 和所有提出的分期系统在 T 分期分类方面均有较好的分离。广州的 T 分期分类在判别能力方面表现最佳(C 指数为 0.6454),其次是第八版 AJCC(0.6451)、第七版 AJCC(0.6386)、香港(0.6376)和广西(0.5889)。对于 N 分期,除了广州的建议外,没有任何分期系统能够改善第七版 AJCC 在区分 N2 和 N1 方面的不足(P=0.096)。此外,广州的 N 分期分类的 C 指数为 0.6444,大于第八版 AJCC(0.6235)、第七版 AJCC(0.6179)、香港(0.6175)和广西(0.6175)。因此,与第八版 AJCC(0.6791)、第七版 AJCC(0.6766)、香港(0.6765)和广西(0.6688)相比,广州分期系统的分期组显示出更高的判别能力(C 指数为 0.6839),尽管 I 期和 II 期仍然无法区分(P=0.322)。

结论

第八版 AJCC 分期系统似乎优于第七版 AJCC。但来自广州的分期系统更有可能提高分期的分离和判别能力。

相似文献

1
Validation and comparison of the 7th and 8th edition of AJCC staging systems for non-metastatic nasopharyngeal carcinoma, and proposed staging systems from Hong Kong, Guangzhou, and Guangxi.验证和比较第 7 版和第 8 版 AJCC 分期系统用于非转移性鼻咽癌,以及来自香港、广州和广西的分期系统。
Oral Oncol. 2017 Sep;72:65-72. doi: 10.1016/j.oraloncology.2017.07.011.
2
Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.比较 UICC/AJCC 第七版和第八版鼻咽癌分期系统:两个中心 1317 例调强放疗患者的分析。
BMC Cancer. 2018 May 29;18(1):606. doi: 10.1186/s12885-018-4419-1.
3
Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era.调强放疗时代来自鼻咽癌高发地区的第 8 版 UICC/AJCC 分期系统的验证。
J Natl Compr Canc Netw. 2017 Jul;15(7):913-919. doi: 10.6004/jnccn.2017.0121.
4
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.调强放射治疗时代AJCC/UICC鼻咽癌分期系统第8版提案
Cancer. 2016 Feb 15;122(4):546-58. doi: 10.1002/cncr.29795. Epub 2015 Nov 20.
5
Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.第八版 AJCC/UICC 鼻咽癌分期系统的验证:来自具有 10 年随访的非流行地区队列的结果。
Oral Oncol. 2019 Nov;98:141-146. doi: 10.1016/j.oraloncology.2019.09.029. Epub 2019 Oct 4.
6
The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement.AJCC/UICC 分期系统(第 7 版)在鼻咽癌中的优势/劣势及未来改进建议。
Oral Oncol. 2012 Oct;48(10):1007-1013. doi: 10.1016/j.oraloncology.2012.03.022. Epub 2012 Apr 22.
7
AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.AJCC 第 7 版分期分类法比 AJCC 第 8 版分期分类法更适用于侵袭性 IPMN。
World J Surg Oncol. 2019 Aug 6;17(1):137. doi: 10.1186/s12957-019-1682-9.
8
A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.中国队列中 UICC/AJCC 鼻咽癌分期系统第六版与第七版的比较。
PLoS One. 2014 Dec 23;9(12):e116261. doi: 10.1371/journal.pone.0116261. eCollection 2014.
9
Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.美国癌症联合委员会(AJCC)第8版胰腺癌患者分期系统的验证:一项监测、流行病学和最终结果(SEER)分析。
Ann Surg Oncol. 2017 Jul;24(7):2023-2030. doi: 10.1245/s10434-017-5810-x. Epub 2017 Feb 17.
10
Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era.比较调强放疗时代 UICC/AJCC 第 7 版和第 8 版鼻咽癌分期系统。
BMC Cancer. 2021 Mar 30;21(1):327. doi: 10.1186/s12885-021-08036-8.

引用本文的文献

1
Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial.多西他赛联合顺铂进行四个周期新辅助化疗后同步放化疗用于N2-3期鼻咽癌:3期多中心随机对照试验
BMJ. 2025 Apr 15;389:e081557. doi: 10.1136/bmj-2024-081557.
2
Long-Term Quality of Life and Functional Outcomes in Patients with Total Laryngectomy.全喉切除患者的长期生活质量和功能结局
Cancers (Basel). 2025 Mar 17;17(6):1011. doi: 10.3390/cancers17061011.
3
Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
EBV DNA 和血小板与淋巴细胞比值对非转移性鼻咽癌患者的预后价值:一项回顾性研究。
BMC Cancer. 2023 Jul 18;23(1):673. doi: 10.1186/s12885-023-11117-5.
4
Prognostic significance of cervical radiologic carotid artery invasion by lymph node on magnetic resonance imaging in nasopharyngeal carcinoma.磁共振成像中颈部影像学颈动脉受淋巴结侵犯对鼻咽癌的预后意义。
Cancer Imaging. 2023 Mar 13;23(1):26. doi: 10.1186/s40644-023-00544-z.
5
Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma.根治性放疗治疗早、晚期治疗后转移性鼻咽癌的临床特征和影响生存的预后因素。
BMC Cancer. 2023 Jan 3;23(1):7. doi: 10.1186/s12885-022-10494-7.
6
Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study.选择和验证接受调强放射治疗的老年鼻咽癌(NPC)患者中的化疗受益人群:一项大型真实世界研究。
Radiat Oncol. 2022 Aug 8;17(1):138. doi: 10.1186/s13014-022-02095-2.
7
A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.一种基于临床特征和血液生物标志物的新型预后模型可预测鼻咽癌患者的总生存期。
Cancer Med. 2021 Jun;10(11):3511-3523. doi: 10.1002/cam4.3839. Epub 2021 May 11.
8
MACC1 Is Associated With Epithelial-Mesenchymal Transition and Can Predict Poor Prognosis in Nasopharyngeal Carcinoma.MACC1与上皮-间质转化相关,并可预测鼻咽癌的不良预后。
Front Oncol. 2021 Mar 29;11:644120. doi: 10.3389/fonc.2021.644120. eCollection 2021.
9
Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era.比较调强放疗时代 UICC/AJCC 第 7 版和第 8 版鼻咽癌分期系统。
BMC Cancer. 2021 Mar 30;21(1):327. doi: 10.1186/s12885-021-08036-8.
10
A Nomogram Based on Serum Biomarkers and Clinical Characteristics to Predict Survival in Patients With Non-Metastatic Nasopharyngeal Carcinoma.基于血清生物标志物和临床特征的列线图预测非转移性鼻咽癌患者的生存率
Front Oncol. 2020 Dec 10;10:594363. doi: 10.3389/fonc.2020.594363. eCollection 2020.